Rome Newsroom, Apr 29, 2021 / 13:00 pm America/Denver (CNA).
An Italian investigative news program has accused the Vatican’s treasury of investing 20 million euros (around $24 million) in several pharmaceutical companies involved in making the “morning-after pill.”
The program “Report,” aired on the channel Rai 3, interviewed the former auditor general of the Vatican, Libero Milone, who said that his office alerted superiors at the Vatican to the “risky” character of the investments.
He also told the program he considered the investments a risk “because they did not correspond to the social doctrine of the Church.”
Milone was the Vatican’s first auditor general, appointed in 2015 by Pope Francis. In 2017, he and his deputy, Ferruccio Pannicco, were forced to resign by Archbishop Angelo Becciu, then sostituto of the Secretariat of State, who accused them of spying.
According to an investigation by “Report,” in 2016, APSA, which functions as the Holy See treasury, sovereign wealth manager, and administers payroll and operating expenses for Vatican City, invested 20 million euros in two Swiss pharmaceutical companies.